Skip To Main Content
Michael Wechsler on Muck Rack

Michael Wechsler

Get in touch with Michael

Contact Michael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Articles

Alarmins and TSLP and Upstream Drivers of Severe Asthma Inflammation

|
By Geoffrey Chupp, Jacqueline Ross, Michael Wechsler, Nicola Hanania
| consultantlive.com
The Evolving Role of Biologics and TSLP Inhibition in Severe Asthma and Upper Airway Disease - Episode 2 Published on: , , , One cytokine sits above the rest. Dr. Hanania explains why TSLP earns the label of master regulator, and why blocking it reaches inflammation that current therapies cannot. This episode, "Alarmins and TSLP: Upstream Drivers of Severe Asthma Inflammation," features Dr. Hanania tracing 32 years of shifting thinking about what starts airway inflammation.
Open in Who Shared View Duplicates (2) Issue with article?

Rethinking Severe Asthma: The Airway Epithelium as an Immune Organ

|
By Geoffrey Chupp, Jacqueline Ross, Michael Wechsler, Nicola Hanania
| consultantlive.com
The Evolving Role of Biologics and TSLP Inhibition in Severe Asthma and Upper Airway Disease - Episode 1 Published on: , , , The airway epithelium is no longer understood as a passive wall. The panel traces how a barrier is now thought of as an immune organ, and what that shift means for severe asthma. Welcome back to another HCPLive Peer Exchange series.
Open in Who Shared View Duplicates (2) Issue with article?

HCPLive Five: Asthma Updates at ATS 2026

|
By Njira L. Lugogo, Brittany Duchene, Simon Couillard, Christian Cardillo, Michael Wechsler
| consultantlive.com
Asthma research took center stage at the 2026 American Thoracic Society (ATS) International Conference in Orlando, Florida, with new data challenging long-held assumptions about who benefits from biologic therapy and how to measure that benefit.
Open in Who Shared Issue with article?
See all 3 articles